Previous close | 1.4800 |
Open | 1.4800 |
Bid | 1.5100 x 400 |
Ask | 1.5600 x 100 |
Day's range | 1.4480 - 1.5300 |
52-week range | 1.1750 - 6.6100 |
Volume | |
Avg. volume | 221,309 |
Market cap | 78.825M |
Beta (5Y monthly) | 1.52 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...
PMV Pharmaceuticals (PMVP) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Here, we discuss some reasons why buying Acrivon Therapeutics (ACRV) stock now may turn out to be a prudent move.